Plasma Metanephrines
[Plasma Metanephrines]
EPTIS Ringversuch Nr. 1616034 | Letze Änderung 2026-09-24 | URL: https://www.eptis.bam.de/pts1616034 https://www.eptis.bam.de/pts1616034
| Name des Anbieters | |||||||||||||
| Name des Anbieters | Birmingham Quality (member of the UK NEQAS Consortium), University Hospitals Birmingham NHS Foundation Trust Birmingham Quality (member of the UK NEQAS Consortium), University Hospitals Birmingham NHS Foundation Trust | ||||||||||||
| Ansässig in | United Kingdom | ||||||||||||
| Sprache(n) | English | ||||||||||||
| Anmerkungen | Provides EQA coverage for Plasma Metanephrines, this includes the anaytes Metanephrine, Normetanephrones and 3 Methoyxtyramine. The plasma metanephrines test is used for the presumptive diagnosis of catecholamine-secreting phaeochromocytomas or paragangliomas. The measurement of plasma metanephrines has been shown to be a highly sensitive test for the detection of phaeochromocytoma - a negative test result virtually rules out the diagnosis. Testing may also be used when a tumour has been treated or removed to monitor for recurrence. The scheme provides both endogenous and manipulated Lyphophised specimens to cover both the normal and pathological concentration ranges. | ||||||||||||
| Klassifizierung | |||||||||||||
| Produktgruppen |
Health care / medical devices
|
||||||||||||
| Prüfgebiete |
Medical analysis
|
||||||||||||
| Technische Einzelheiten | |||||||||||||
|
|||||||||||||
| Ringversuchsziele | |||||||||||||
| Zielgruppe des Ringversuchs | Clinical Chemistry Public & Private Labs | ||||||||||||
| Relevante Rechtsvorschriften oder Normen | ISO/IEC 17043:2023 | ||||||||||||
| Weitere Ziele | Post market surveillance of testing methods | ||||||||||||
| Teilnehmerzahl | |||||||||||||
| Anbieter unabhängig überprüft (akkreditiert, benannt, anerkannt) |
Akkreditiert durch UKAS auf der Grundlage von ISO/IEC 17043:2023 |
||||||||||||
| Die Durchführung des Ringversuchs ist in Auftrag gegeben durch | |||||||||||||
| Kosten | |||||||||||||
| Teilnahmegebühr | Contact provider for current fee, which depends on location and extent of service required. | ||||||||||||
| Regelmässig durchgeführt | Ja (Monthly (11 per year)) | ||||||||||||
| Der Ringversuch wird durchgeführt seit | 2023 | ||||||||||||
| Kontaktdaten des Anbieters | |||||||||||||
| Anbieter | Kontaktperson | ||||||||||||
|
Birmingham Quality (member of the UK NEQAS Consortium), University Hospitals Birmingham NHS Foundation Trust
Queen Elizabeth Medical Centre P O Box 3909 B15 2SQ Birmingham United Kingdom Telefon: +44 121 414 7300 Fax: Web: https://www.birminghamquality.org.uk https://www.birminghamquality.org.uk |
Birmingham Quality
Telefon: +44 121 414 7300 Fax: E-Mail: birminghamquality@uhb.nhs.uk birminghamquality@uhb.nhs.uk |
||||||||||||
Haben Sie einen Fehler entdeckt? Bitte wenden Sie sich an den zuständigen EPTIS Koordinator für United Kingdom,
Mr Savvas Xystouris.
Mr Savvas Xystouris.